Study title: USPDI Parenteral Dosage Forms, Antihistamines (Systemic) Diphenhydramine Hydrochloride Injection USP, United States Pharmacopoeia Dispensing InformationUSPDI Parenteral Dosage Forms, Antihistamines (Systemic) Diphenhydramine Hydrochloride Injection USP, United States Pharmacopoeia Dispensing Information
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia [E03] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DIPHENHYDRAMINE_OR DIPHENHYDRAMINE AND CHLORHEXIDINE | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |